Botanical species · safety record

Polygonatum odoratum

The EFSA Compendium of Botanicals holds 6 constituent measurements and 1 adverse-effect record for Polygonatum odoratum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Polygonatum odoratum Druce

6Constituent measurements
1Safety records
5Cited sources
108Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 108 licensed products naming Polygonatum odoratum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Dried Herb top and Root
  • Polygonum cuspidatum - rhizome
  • Radix
  • Rhizoma
  • Rhizome
  • Rhizome Extract
  • Rhizome(s)
  • Root and rhizome

What the records describe

Constituents measured

  • Imidazole alkaloids1
  • Isoflavones1
  • Lectins1
  • Lignans1
  • Saponins1
  • Steroidal saponins1

Plant parts

  • Roots and other underground parts5
  • Unspecified2

Preparations

  • Solvent extraction6

Effect types

  • Digestive1

Target tissues

  • Digestive: pancreas1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Imidazole alkaloidsRoots and other underground partsSolvent extraction9.23 Milligram/gramGC-MSResolve DOI
IsoflavonesRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LignansRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SaponinsUnspecifiedUnspecifiedResolve DOI
Steroidal saponinsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LectinsUnspecifiedSolvent extractionUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestive: pancreasRoots and other underground partsSolvent extractionIn vitroResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Quan, Ling-Tong., Wang, Shao-Chen., Zhang, Jing. Chemical constituents from Polygonatum odoratum. BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2015, vol. 58, p. 281-284. DOI
  2. Wu, Lei., Liu, Tao., Xiao, Yan., Li, Xin., Zhu, Yanan., Zhao, Yan., Bao, Jinku., Wu, Chuanfang. Polygonatum odoratum lectin induces apoptosis and autophagy by regulation of microRNA-1290 and microRNA-15a-3p in human lung adenocarcinoma A549 cells. International journal of biological macromolecules, 2016, p. 217-226.
  3. Zhou, Xiaoling., Liang, Junsheng., Zhang, Yi., Zhao, Huading., Guo, Ying., Shi, Shuyun. Separation and purification of alpha-glucosidase inhibitors from Polygonatum odoratum by stepwise high-speed counter-current chromatography combined with Sephadex LH-20 chromatography target-guided by ultrafiltration-HPLC screening. AND LIFE SCIENCES, 2015, vol. 985, p. 149-154. DOI
  4. Elekofehinti, O.O. Saponins: Anti-diabetic principles from medicinal plants - A review. Pathophysiology, 2015, vol. 22, no. 2, p. 95-103. DOI
  5. Baek, Seung-Hoon., Lee, Jin Gyun., Park, Seo Young., Piao, Xiang-Lan., Kim, Hyun Young., Bae, Ok-Nam., Park, Jeong Hill. Gas chromatographic determination of azetidine-2-carboxylic acid in rhizomes of Polygonatum sibiricum and Polygonatum odoratum. JOURNAL OF FOOD COMPOSITION AND ANALYSIS, 2012, vol. 25, no. 2, p. 137-141. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue